| Primary |
| Non-small Cell Lung Cancer |
23.8% |
| Lung Neoplasm Malignant |
13.2% |
| Lung Adenocarcinoma |
11.6% |
| Hypertension |
8.1% |
| Constipation |
5.2% |
| Pain |
4.6% |
| Cancer Pain |
4.3% |
| Insomnia |
4.1% |
| Squamous Cell Carcinoma |
3.0% |
| Prophylaxis |
3.0% |
| Cough |
2.9% |
| Gastritis |
2.7% |
| Rash |
2.6% |
| Nausea |
1.9% |
| Diarrhoea |
1.8% |
| Diabetes Mellitus |
1.7% |
| Gastric Ulcer |
1.7% |
| Osteoporosis |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Non-small Cell Lung Cancer Stage Iv |
1.2% |
|
| Rash |
12.3% |
| Lung Disorder |
9.5% |
| Hepatic Function Abnormal |
8.5% |
| Disease Progression |
8.0% |
| Interstitial Lung Disease |
7.8% |
| Pneumonia |
7.3% |
| Vomiting |
6.9% |
| Liver Disorder |
5.4% |
| Pyrexia |
5.0% |
| Death |
3.7% |
| Diarrhoea |
3.0% |
| Respiratory Failure |
2.9% |
| Anaemia |
2.8% |
| Weight Decreased |
2.7% |
| Dyspnoea |
2.5% |
| Liver Function Test Abnormal |
2.3% |
| Pulmonary Embolism |
2.3% |
| Thrombocytopenia |
2.3% |
| White Blood Cell Count Decreased |
2.3% |
| Stomatitis |
2.3% |
|
| Secondary |
| Lung Adenocarcinoma |
13.3% |
| Non-small Cell Lung Cancer |
12.4% |
| Hypertension |
12.1% |
| Prophylaxis |
8.9% |
| Lung Neoplasm Malignant |
6.0% |
| Constipation |
5.7% |
| Rash |
4.2% |
| Cancer Pain |
4.2% |
| Pain |
4.0% |
| Oropharyngeal Cancer Stage Unspecified |
3.4% |
| Insomnia |
3.3% |
| Hyperuricaemia |
3.2% |
| Squamous Cell Carcinoma |
3.1% |
| Cough |
3.0% |
| Gastritis |
2.6% |
| Radiation Dysphagia |
2.6% |
| Non-small Cell Lung Cancer Stage Iv |
2.3% |
| Osteoporosis |
2.0% |
| Gastric Ulcer |
1.9% |
| Hypercreatininaemia |
1.8% |
|
| Rash |
13.8% |
| Hepatic Function Abnormal |
11.9% |
| Liver Disorder |
10.3% |
| Vomiting |
8.6% |
| Pyrexia |
6.8% |
| Renal Failure |
5.6% |
| Pneumonia |
5.4% |
| Sudden Death |
4.2% |
| Lung Disorder |
4.0% |
| Interstitial Lung Disease |
3.7% |
| Blood Creatinine Increased |
3.5% |
| Respiratory Failure |
3.3% |
| Stomatitis |
3.0% |
| Weight Decreased |
2.8% |
| Thrombocytopenia |
2.6% |
| Pulmonary Alveolar Haemorrhage |
2.3% |
| Anaemia |
2.1% |
| Fatigue |
2.1% |
| Nausea |
2.1% |
| Wound Dehiscence |
2.1% |
|
| Concomitant |
| Breast Cancer |
19.7% |
| Breast Cancer Metastatic |
14.2% |
| Metastases To Bone |
9.2% |
| Lung Adenocarcinoma |
7.1% |
| Non-small Cell Lung Cancer |
7.1% |
| Lung Neoplasm Malignant |
6.9% |
| Prophylaxis |
6.4% |
| Product Used For Unknown Indication |
5.4% |
| Hypertension |
3.4% |
| Lung Adenocarcinoma Stage Iv |
3.2% |
| Lung Adenocarcinoma Metastatic |
3.0% |
| Depression |
2.4% |
| Pain Management |
2.4% |
| Cancer Pain |
1.7% |
| Nausea |
1.5% |
| Abdominal Pain Upper |
1.3% |
| Back Pain |
1.3% |
| Insomnia |
1.3% |
| Metastases To Bone Marrow |
1.3% |
| Pain |
1.3% |
|
| Rash |
10.8% |
| Vomiting |
9.5% |
| Tooth Extraction |
8.1% |
| Hepatic Function Abnormal |
6.8% |
| Liver Disorder |
5.4% |
| Malaise |
5.4% |
| Pulmonary Oedema |
5.4% |
| Weight Decreased |
5.4% |
| Wound Debridement |
5.4% |
| Hypoglycaemia |
4.1% |
| Pyrexia |
4.1% |
| Renal Failure Acute |
4.1% |
| Tooth Disorder |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Wound |
4.1% |
| Cerebral Infarction |
2.7% |
| Fall |
2.7% |
| Leukoencephalopathy |
2.7% |
| Oral Disorder |
2.7% |
| Pathological Fracture |
2.7% |
|
| Interacting |
| Atrial Fibrillation |
36.4% |
| Lung Adenocarcinoma |
18.2% |
| Non-small Cell Lung Cancer |
18.2% |
| Supraventricular Extrasystoles |
18.2% |
| Lung Neoplasm Malignant |
9.1% |
|
| Drug Interaction |
83.3% |
| Liver Disorder |
16.7% |
|
